Jeff Hatfield, CEO of Vitae Pharmaceuticals, welcomed BIO 2015 to his home town of Philly through a blog post in Life Sci VC, sharing his thoughts on the city’s historic legacy of innovation and collaboration.
Hatfield noted: “Innovation is what defines our industry; and collaboration – well, more than 30 thousand collaboration partnering meetings are expected to occur at the convention next week.” The blog post explains that Philadelphia is undergoing an important transition in the life sciences and the outcome is uncertain.
“While some scientists have chosen to leave the area due to the consolidation, many others are staying and creating. They have driven the formation of more than 400 new R&D based ventures since 2008, according to PA Bio, including biotech start-ups, CROs and other specialty and research-focused niche companies.”
Read the full post to learn more about science advancements being made at local Philly institutions and for Jeff’s advice on where to get (and how to order) the best cheesesteak!